Nexus Surgical and Medicare Ltd Reports Strong FY26 Growth

Net Profit (FY 2026): ₹0.74 crore
Total Income (FY 2026): ₹7.90 crore

Reader Takeaway: Robust revenue and profit growth year-on-year; persistent accumulated reserve deficit remains a key concern.

What just happened

Nexus Surgical and Medicare Limited announced its audited financial results for the fiscal year ended March 31, 2026. The company reported a total income of ₹7.90 crore (₹789.63 lakh), a significant increase of 37.85% from ₹5.73 crore (₹572.83 lakh) in FY 2025. Net profit saw an even sharper rise of 47.99%, reaching ₹0.74 crore (₹73.61 lakh) in FY 2026, up from ₹0.50 crore (₹49.74 lakh) in the previous fiscal year. Earnings Per Share (EPS) basic grew by 48.35% to ₹1.35 from ₹0.91.

Why this matters

The strong year-on-year growth in both revenue and profitability indicates a positive operational performance for Nexus Surgical. Improved profitability, outpacing revenue growth, suggests enhanced operating efficiency. An unmodified audit opinion from the statutory auditors provides confidence in the accuracy of the reported financial figures. The appointment of internal auditors for FY 2026-27 also signals adherence to corporate governance standards.

The backstory

Nexus Surgical and Medicare has been working towards improving its financial health. While the company has shown revenue and profit growth in the current fiscal year, a notable point of concern has been its accumulated reserve deficit. As of March 31, 2026, the 'Reserve excluding revaluation reserves' showed a negative balance of ₹3.67 crore (₹367.21 lakh), though this is an improvement from the ₹4.41 crore deficit in the prior year.

What changes now

Investors will closely monitor the company's continued ability to grow its top and bottom lines. The reduction in the accumulated reserve deficit is a positive step, but its continued presence means the company is still operating with negative reserves. Future financial performance will be key to addressing this structural financial weakness.

Risks to watch

The primary risk remains the substantial accumulated reserve deficit. Continued losses or insufficient profits could exacerbate this situation. Sustaining the current growth momentum is also crucial to address this deficit over the long term.

Peer comparison

As a specialized surgical and Medicare company, Nexus Surgical operates in a sector with growing demand for healthcare services. However, specific financial comparisons are difficult without more detailed public data on its direct competitors' recent performance, especially regarding reserve levels.

Context metrics (time-bound)

• Total Income increased by 37.85% to ₹7.90 crore in FY 2026 from ₹5.73 crore in FY 2025.
• Net Profit increased by 47.99% to ₹0.74 crore in FY 2026 from ₹0.50 crore in FY 2025.
• Accumulated reserve deficit reduced to ₹3.67 crore in FY 2026 from ₹4.41 crore in FY 2025.
• Net cash generated from operating activities was ₹0.17 crore in FY 2026, up from ₹0.10 crore in FY 2025.

What to track next

Investors should look for the company's ability to maintain its revenue growth trajectory, further improve profitability, and continue reducing the accumulated reserve deficit in the upcoming fiscal year.